Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis - PubMed (original) (raw)

Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis

R L Goldberg et al. Arthritis Rheum. 1991 Jul.

Abstract

Plasma levels of hyaluronate (HA) in patients with rheumatoid arthritis (RA) and patients with osteoarthritis (OA), measured by enzyme-linked immunosorbent assay, were compared with levels in a healthy, age-matched non-arthritic control group, in a retrospective study. Compared with the controls, the mean level of plasma HA was sevenfold higher in the RA group and twofold higher in the OA group. There was no statistically significant correlation between HA levels and 7 other clinical and biochemical parameters in patients with RA. In the OA group, however, plasma HA levels were found to correlate with an objective functional capacity score and with an articular index based on the total amount of cartilage in involved joints. In a retrospective longitudinal study of 6 patients with RA, plasma levels of HA did not show a significant correlation with plasma levels of elastase or with the erythrocyte sedimentation rate. These data support in part the contention that plasma HA may be unique as a marker, in that it may be a reflection of synovial involvement and inflammation, rather than only of inflammation, in arthritis.

PubMed Disclaimer

Comment in

Clinical significance of hyaluronan in rheumatic diseases: comment on the articles by Goldberg et al and Woessner.
Jouzeau JY, Payan E, Gillet P, Péré P, Netter P, Gaucher A. Jouzeau JY, et al. Arthritis Rheum. 1992 Oct;35(10):1253-4. doi: 10.1002/art.1780351025. Arthritis Rheum. 1992. PMID: 1418015 No abstract available.

Cited by

Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis.
Ishijima M, Watari T, Naito K, Kaneko H, Futami I, Yoshimura-Ishida K, Tomonaga A, Yamaguchi H, Yamamoto T, Nagaoka I, Kurosawa H, Poole RA, Kaneko K. Ishijima M, et al. Arthritis Res Ther. 2011 Feb 14;13(1):R22. doi: 10.1186/ar3246. Arthritis Res Ther. 2011. PMID: 21320321 Free PMC article.
CD44 in rheumatoid arthritis.
Naor D, Nedvetzki S. Naor D, et al. Arthritis Res Ther. 2003;5(3):105-15. doi: 10.1186/ar746. Epub 2003 Feb 28. Arthritis Res Ther. 2003. PMID: 12723975 Free PMC article. Review.
Osteogenic protein 1 in synovial fluid from patients with rheumatoid arthritis or osteoarthritis: relationship with disease and levels of hyaluronan and antigenic keratan sulfate.
Chubinskaya S, Frank BS, Michalska M, Kumar B, Merrihew CA, Thonar EJ, Lenz ME, Otten L, Rueger DC, Block JA. Chubinskaya S, et al. Arthritis Res Ther. 2006;8(3):R73. doi: 10.1186/ar1947. Epub 2006 Apr 28. Arthritis Res Ther. 2006. PMID: 16646979 Free PMC article.
Effect of air pollution and environmental tobacco smoke on serum hyaluronate concentrations in school children.
Fuji Y, Shima M, Ando M, Adachi M, Tsunetoshi Y. Fuji Y, et al. Occup Environ Med. 2002 Feb;59(2):124-8. doi: 10.1136/oem.59.2.124. Occup Environ Med. 2002. PMID: 11850556 Free PMC article.
Fragmented hyaluronan has no alarmin function assessed in arthritis synovial fibroblast and chondrocyte cultures.
Olsson M, Bremer L, Aulin C, Harris HE. Olsson M, et al. Innate Immun. 2018 Feb;24(2):131-141. doi: 10.1177/1753425918759590. Innate Immun. 2018. PMID: 29495940 Free PMC article.

Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis - PubMed (original) (raw)